Home / Import refusals / SCS-4895354-6/10003/1

FDA Import Refusal SCS-4895354-6/10003/1 — Boehringer Ingelheim RCV GmbH & Co KG

Boehringer Ingelheim RCV GmbH & Co KG — FEI 3003433722

The FDA refused shipment SCS-4895354-6/10003/1 from Boehringer Ingelheim RCV GmbH & Co KG (Austria) on October 28, 2025. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 118

Refusal Details

Date
October 28, 2025
Country
Austria
Product Category
Drugs and Biologics
Product Code
61PCA73 EMPAGLIFLOZIN (ANTI-DIABETIC)
Charges
118

Recent inspections

  • 1327044 (VAI Fri Jul 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1258048 (NAI Tue Nov 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1210971 (NAI Thu Mar 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1182096 (NAI Fri Sep 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1170761 (VAI Thu Jan 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources